SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-104965
Filing Date
2018-04-02
Accepted
2018-04-02 17:04:56
Documents
8
Period of Report
2018-03-29
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d549891d8k.htm 8-K 16291
2 EX-10.1 d549891dex101.htm EX-10.1 144540
3 GRAPHIC g549891dsp011.jpg GRAPHIC 9952
4 GRAPHIC g549891dsp015.jpg GRAPHIC 8074
5 GRAPHIC g549891dsp016.jpg GRAPHIC 7542
6 GRAPHIC g549891dsp017.jpg GRAPHIC 9376
7 GRAPHIC g549891page015.jpg GRAPHIC 45113
8 GRAPHIC g549891page017.jpg GRAPHIC 129878
  Complete submission text file 0001193125-18-104965.txt   451078
Mailing Address 9987 CARVER ROAD CINCINNATI OH 45242
Business Address 9987 CARVER ROAD CINCINNATI OH 45242 (513) 985-1920
Aerpio Pharmaceuticals, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-53057 | Film No.: 18729940
SIC: 2834 Pharmaceutical Preparations